Pancreatic Cancer Research

ResearcherThe University of Texas Southwestern Medical CenterNo recent work listed

Moriah M. Hagopian

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5050615982. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper

Papers 4

  1. Targeting TGFβR2-mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer. Co-author DOI 10.15252/emmm.201910515↗
  2. Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1535-7163.mct-16-0834↗
  3. Stromal TGFβR2 signaling: a gateway to progression for pancreatic cancer. Co-author DOI 10.4161/23723556.2014.975606↗
  4. Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis. Co-author DOI 10.1158/0008-5472.can-13-1807↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rolf A. Brekken · 4 shared papers, 2014–2019 · strength 0.28
  2. Wenting Du · 2 shared papers, 2017–2019 · strength 0.14
  3. Huocong Huang · 2 shared papers, 2017–2019 · strength 0.14
  4. Mohamed Zaid · 1 shared paper, 2019 · strength 0.08
  5. Yuqing Zhang · 1 shared paper, 2019 · strength 0.08
  6. Abdel Nasser Hosein · 1 shared paper, 2019 · strength 0.08
  7. Eugene Jon Koay · 1 shared paper, 2019 · strength 0.08
  8. Kristina Y. Aguilera · 1 shared paper, 2017 · strength 0.06
  9. Huamin Wang · 1 shared paper, 2017 · strength 0.06
  10. Jason B. Fleming · 1 shared paper, 2017 · strength 0.06
  11. Katherine T. Ostapoff · 1 shared paper, 2014 · strength 0.04
  12. Mary Topalovski · 1 shared paper, 2014 · strength 0.04
  13. Bercin Kutluk Cenik · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.